The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

GEMO Study Collaborators, EMBRACE Collaborators, OCGN Investigators, HEBON Investigators, KConFab Investigators

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Keyphrases